相关实验视频

Updated: May 25, 2025

Development of Recombinant Proteins to Treat Chronic Pain

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

针对状细胞病理生物学和疼痛,使用新型的透皮黄素

Yugal Goel¹, Mya A Arellano¹, Raghda T Fouda¹

¹Hematology/Oncology Division, Department of Medicine, University of California, Irvine, CA 92697, USA.

|February 26, 2025

概括

一种新的透皮黄凝有效地治疗了小鼠状细胞病 (SCD) 的症状. 这种局部治疗改善红细胞的稳定性,并减少与SCD相关的疼痛和炎症.

科学领域:

药理学药理学是指药理学的学科.
血液学血液学血液学
生物化学生化学

背景情况:

状细胞疾病 (SCD) 涉及红细胞 (RBC) 不稳定,炎症和氧化应激,导致并发症.
目前的治疗方法缺乏慢性治疗的可扩展性和成本效益.
黄素看起来很有前途,但其口服生物可用性很差.

研究的目的:

开发和评估一种新的局部/透皮 (TD) 黄凝配方用于SCD.
在临床前的SCD模型中评估TD黄素的生物可用性和治疗疗效.

主要方法:

一种新型的TD黄凝被制成.
在血和血细胞中评估了生物可用性.
在人性化的状细胞小鼠中评估了疗效,测量了疼痛,红细胞稳定性,氧化应激,炎症和巨细胞激活.

主要成果:

TD曲素凝显示出快速和高的生物可用性.
它改善了小鼠的疼痛过敏和轴突损伤.
观察到红细胞不稳定性,血液溶解和氧化损伤的减少.
关键的促炎细胞因子和巨细胞激活的水平下降.

结论:

新型TD黄凝配方在临床前SCD模型中具有生物可用性和有效性.
它有可能缓解慢性疼痛并减少SCD的炎症后果.
这种配方为SCD管理提供了一个有希望的,易于使用的治疗策略.

关键词:

库尔库明是一种黄素.这是一种炎症炎症炎症炎症.疼痛疼痛疼痛疼痛红细胞是红血细胞的组成部分.状细胞疾病是一种状细胞疾病.

更多相关视频

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.